Bouvel Investment Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-243,672
Closed -$1.17M 79
2025
Q4
$1.17M Sell
243,672
-2,561
-1% -$12.4K 0.34% 68
2025
Q3
$1.25M Sell
246,233
-9,237
-4% -$40.8K 0.38% 67
2025
Q2
$1.03M Sell
255,470
-13,397
-5% -$43.6K 0.35% 64
2025
Q1
$790K Buy
268,867
+3,434
+1% +$12.3K 0.3% 72
2024
Q4
$1.13M Sell
265,433
-3,434
-1% -$13.1K 0.41% 62
2024
Q3
$790K Sell
268,867
-2,058
-0.8% -$6.55K 0.3% 72
2024
Q2
$943K Buy
270,925
+1,958
+0.7% +$6.53K 0.36% 66
2024
Q1
$767K Buy
268,967
+89,353
+50% +$276K 0.33% 68
2023
Q4
$634K Buy
179,614
+4,453
+3% +$12.8K 0.3% 72
2023
Q3
$454K Buy
+175,161
New +$615K 0.25% 74

Other funds holding SRTA

Bouvel Investment Partners's SRTA Position: Q1 2026 in Review

Bouvel Investment Partners sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 243,672 shares — an estimated $1.17M sold.

Bouvel Investment Partners first reported a position in SRTA in Q3 2023 and held it in 10 quarters. The position peaked at $1.25M in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Bouvel Investment Partners reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
  • Bouvel Investment Partners sold 243,672 Strata Critical Medical Inc shares in Q1 2026, an estimated $1.17M.
  • Bouvel Investment Partners first reported a position in Strata Critical Medical Inc in Q3 2023 and held it in 10 quarters.
  • Bouvel Investment Partners's Strata Critical Medical Inc position peaked at $1.25M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Bouvel Investment Partners's 13F filing for Q1 2026, filed 10 Apr 2026.